Investments - Schedule of Investments (Parenthetical) (Details) ¥ in Thousands, $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2025
CNY (¥)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
CNY (¥)
|
Dec. 31, 2023
CNY (¥)
|
|
| Investments. | ||||
| Impairment charges for equity investments without readily determinable fair value | ¥ 43,698 | ¥ 166,127 | ¥ 210,813 | |
| Credit impairment related to available-for-sale debt investments | 66,339 | 14,987 | ||
| Fair value changes | 120,027 | 145,458 | 35,811 | |
| Due to investments amortized cost basis exceeded fair value | 65,260 | |||
| Credit loss related to available-for-sale debt investments | 76,458 | 1,079 | ||
| Non-credit losses | (43,569) | (79,119) | 20,824 | |
| Cash consideration | 24,000 | $ 3,432 | 0 | 68,332 |
| Share of loss in equity method investments, net of income taxes | ¥ 2,695 | $ 385 | ¥ 0 | ¥ 0 |
| X | ||||||||||
- Definition Amount of expense for credit fair value changes on available-for-sale debt investments. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for credit impairment on available-for-sale debt investments. No definition available.
|
| X | ||||||||||
- Definition Amount of credit loss recognized on investment in debt security in net loss. No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss recorded in net loss due to that the investments' amortized cost basis exceeding fair values and the Group's current intention to sell the investments. No definition available.
|
| X | ||||||||||
- Definition Amount of non-credit losses on available-for-sale debt investments, which was reported in other comprehensive income (loss). No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|